Presentations from the 2020 STD Prevention Conference

Posted on
2020 STD Prevention Conference Logo

Click on the title of the presentation below to watch an archived video. Pelvic Inflammatory Disease Biomarkers for Diagnosing PID: Where Are We? Sharon Hillier, PhD University of Pittsburgh School of Medicine The Epidemiology of Pelvic Inflammatory Disease in the United States Kristen Kreisel, PhD Centers for Disease Control and Prevention Does Screening for Chlamydia […]

Presentations from the 2018 STD Prevention Conference

Posted on
2018 STD Prevention Conference

Click on the title of the presentations below to watch an archived video from the conference. Debate: Should Health Departments Stop Active Surveillance and Partner Services for Chlamydia? PRO Joan Chow, DrPH, MPH California Department of Public Health, CA CON William Miller, MD, PhD The Ohio State University, OH The Population-Level Impact of Screening Women […]

Presentations from the 2016 STD Prevention Conference

Posted on

New Directions in Adolescent Risk What’s Different about Detroit’s School Screening Program? Research Aimed at Explaining Results Showing 5 Consecutive Years of Declines in CT Prevalence Detroit’s school-based STD screening program is the first such program to be associated with a sustained reduction in chlamydia prevalence. Richard Louis Dunville, MPH, Division of Adolescent and School […]

Extra-Genital Chlamydia and Gonorrhea Infections

Posted on

By John Papp, PhD Chlamydia and gonorrhea infections are common in non-genital sites in some populations such as men who have sex with men (MSM). Be-cause extra-genital infections are common in MSM and most infections are asymptomatic1, routine annual screening of extra-genital sites in MSM is recommended. No recommendations exist regarding routine extra-genital screening in […]

Updates to the USPSTF Chlamydia Screening Guidelines: A Delicate Balance Between Evidence and Action

Posted on

Commentary by Joan M. Chow, MPH, DrPH, Chief, Surveillance, Epidemiology, Assessment, and Evaluation Section, California Department of Public Health-Sexually Transmitted Disease Control Branch Although over 1.4 million chlamydia cases were reported to the Centers for Disease Control and Prevention (CDC) in 2013, there are potentially two to three times that number of infections as a […]

Laboratory Considerations for Male Chlamydia Screening

Posted on

Men provide a reservoir for continued transmission of C. trachomatis to women, thus representing a population for potential targeted screening. There are no formal recommendations by professional organizations for screening men for chlamydia, however, guidance has been provided by the Centers for Disease Control and Prevention (CDC) for clinical sites wishing to screen men, who […]